The mood in Wall Street is upbeat as the S&P 500 has risen 2.2% in the week ending Nov 13. The 30-stock Dow Jones Industrial Average has also rallied more than 4% in the week, hitting an intra-day record (according to a CNBC article).
The recent coronavirus antibody and vaccine development raises hopes of a vaccine soon. On Nov 9, Pfizer (PFE) and BioNTech announced the efficacy of their mRNA-based coronavirus vaccine candidate, BNT162b2. According to the companies, the vaccine was more than 90% successful in preventing COVID-19 in participants without prior evidence of SARS-CoV-2 infection. The results are based on the first interim efficacy analysis conducted on Nov 8, by an external, independent Data Monitoring Committee from the Phase 3 clinical study, per the company. The news has instilled optimism in the market.
Meanwhile, total number of coronavirus cases has crossed 54 million globally. Notably, the world’s largest economy has seen more than 11 million cases alone. Thus, the worsening coronavirus crisis is raising desperation among investors over the introduction of a vaccine.
On the other hand, Eli Lilly and Company (LLY) recently announced that its investigational neutralizing antibody bamlanivimab (LY-CoV555) 700 mg has been awarded Emergency Use Authorization (EUA) by the FDA.
Moreover, the chances of a divided Congress in the United States seem more likely, where Republicans can continue to control the Senate and Democrats, the House. Thus, as a result of this political gridlock, major and stringent changes in the corporate tax policies will be very difficult to implement in the medium-term. Thus, easing worries regarding major policy changes are making the investing environment more friendly for market participants.
Going on, the United States is pleasantly surprising market participants with upbeat economic data. Notably, the world’s largest economy delivered an impressive performance in third-quarter 2020, beating market expectations. Going by, the Department of Commerce’s report on Oct 29, GDP surged to a record high at an annualized pace of 33.1% after declining 31.4% in the second quarter.
The manufacturing sector is also picking up despite the coronavirus crisis. According to the Institute for Supply Management (ISM) report on Nov 2, its Purchasing Managers' Index (PMI) for manufacturing surged to 59.3% in October, increasing 3.4 points from last month and surpassing the consensus estimate of 55.9%. In fact, the October figure stood out as the highest PMI reading since September 2018.
Furthermore, the housing market continues to be a bright spot in the U.S. economy as it recently delivered a streak of encouraging data. The recently-released data on the U.S. builder confidence was impressive as well. Per the monthly NAHB/Wells Fargo Housing Market Index (HMI),
builder confidence for newly-built single-family homes rose to an all-time high of 85 points in October in comparison to 83 points in September, 78 in August and 72 in July. Low interest rates are boosting demand in the housing market and resulting in a rise in mortgage applications. ETF Strategies to Follow
Here we discus certain ETF strategies to help investors make the most of the upbeat U.S. economic data amid the coronavirus crisis:
Momentum ETFs to Consider
While the broader stock market is expected to gain on optimism surrounding the rebounding U.S. economy and positive developments in coronavirus vaccine research, momentum investing will likely take centerstage as investors seek greater returns in the short term. Momentum investing looks to fetch profits from hot stocks that have shown an uptrend over the past few weeks or months. Investors can consider
iShares Edge MSCI USA Momentum Factor ETF ( MTUM Quick Quote MTUM - Free Report) , Invesco DWA Momentum ETF ( PDP Quick Quote PDP - Free Report) , Invesco S&P MidCap Momentum ETF (XMMO), VictoryShares USAA MSCI USA Value Momentum ETF (ULVM) and SPDR Russell 1000 Momentum Focus ETF (ONEO) (read: Here's Why it is the Right Time to Invest in Momentum ETFs). Growth ETFs to Play
Growth stocks are generally expected to witness a positive revenue and earnings trend at a faster rate than the industry average. As such, growth funds tend to outperform during an uptrend. While there are several options in the growth ETF world, we have highlighted five funds that offer broad-based exposure to the U.S. stock market like
Vanguard Growth ETF ( VUG Quick Quote VUG - Free Report) , Schwab U.S. Large-Cap Growth ETF ( SCHG Quick Quote SCHG - Free Report) , iShares Core S&P U.S. Growth ETF ( IUSG Quick Quote IUSG - Free Report) , SPDR S&P 500 Growth ETF (SPYG) and Vanguard Mega Cap Growth ETF (MGK) (read: Here's Why Growth ETFs Are Sizzling With Opportunities). Large-Cap ETFs to Look Out For
With the U.S. economy gradually looking up, it makes sense to bet on large-cap ETFs as these funds perform well in such scenarios. Therefore, investors can consider
SPDR S&P 500 ETF Trust ( SPY Quick Quote SPY - Free Report) , iShares Core S&P 500 ETF ( IVV Quick Quote IVV - Free Report) , Vanguard S&P 500 ETF ( VOO Quick Quote VOO - Free Report) , Schwab U.S. Large-Cap ETF ( SCHX Quick Quote SCHX - Free Report) , iShares Russell Top 200 ETF (IWL), Vanguard Mega Cap ETF (MGC) and Multifactor Large Cap ETF (JHML) (read: ETFs Riding the Latest Coronavirus Vaccine Optimism Wave). Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.
Get it free >>